Varian Medical Systems, Inc. and Subsidiaries

United States Tax Court·Decided April 8, 2026·No. 8435-23·Published

Opinion

United States Tax Court

166 T.C. No. 8

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES, Petitioner

v.

COMMISSIONER OF INTERNAL REVENUE, Respondent

Held: The Court will not treat R as having forfeited his argument concerning I.R.C. § 246 or P as having forfeited its argument concerning I.R.C. § 245A(d)(1).

Held, further, I.R.C. § 246 disallows a portion of P’s DRD under I.R.C. § 245A.

Held, further, the formula used to compute P’s foreign tax credit disallowance under I.R.C. § 245A(d)(1) must include the post-I.R.C. § 965(c) amount in the denominator of the fraction.

Held, further, R’s Motion will be granted, and P’s Motion will be denied.

operated in tandem with the pre-TCJA version of section 78 for a time. Varian was one such taxpayer. Therefore, for its 2018 tax year, we concluded that Varian was entitled to a deduction under section 245A related to gross-up amounts it included in income as a dividend under the prior version of section 78.

Second, we considered whether, in view of our first holding, new section 245A(d)(1) limited the amount of foreign tax credits Varian would be entitled to claim. On this issue, we agreed with the Commissioner and held that Varian’s foreign tax credits would be limited.

After we issued the opinion, Varian and the Commissioner worked to compute Varian’s deduction under section 245A and its disallowed foreign tax credits under section 245A(d)(1). Now before us are Cross-Motions for Summary Judgment addressing disputes that arose during that process. Both parties argue that we should deem certain points raised by the Motions forfeited or abandoned because the other party did not raise them earlier.

For its part, Varian maintains that the Commissioner has forfeited any argument that section 246 disallows a portion of Varian’s claimed deduction under section 245A, and, in any event, section 246 allows Varian’s claimed deduction in full. Varian further contends that, in determining the amount of its foreign tax credit disallowance under section 245A(d)(1), Varian’s net section 965 inclusion must be determined without regard to section 965(c).

The Commissioner disagrees with Varian on each of its three points. Additionally, the Commissioner maintains that Varian has forfeited any arguments regarding the section 245A(d)(1) disallowance.

For the reasons below, we will not treat the parties’ arguments as forfeited and resolve the remaining issues in favor of the Commissioner.

Background

The following facts are derived from the parties’ pleadings and Motion papers. 2 They are stated solely for the purpose of ruling on the

2 Many of these facts were included in our prior opinion. We repeat them here

for the reader’s convenience.

Motions before us and not as findings of fact in this case. See Rowen v. Commissioner, 156 T.C. 101, 103 (2021) (reviewed).

Originally founded in 1948, Varian is the parent company of a consolidated group of medical device and software manufacturers. Its principal place of business is in Palo Alto, California.

Varian operates through corporations in many different countries, at least some of which are controlled foreign corporations (CFCs) as that term is defined in section 957(a). Varian and its CFCs are fiscal year taxpayers, meaning their taxable years do not end on December 31. See I.R.C. § 441(a), (d), (e). As relevant for this case, the fiscal year of Varian and its CFCs started on September 30, 2017, and ended on September 28, 2018 (2018 Year).

During the 2018 Year, 22 CFCs owned directly and indirectly by Varian and members of its U.S. consolidated group had Accumulated Post-1986 Deferred Foreign Income, as defined in section 965 and the regulations thereunder. Shares in nine of those CFCs were held directly by a member of Varian’s U.S. consolidated group (first-tier CFCs). Shares in the remaining 13 CFCs were held indirectly (i.e., through one or more foreign corporations) by a member of Varian’s U.S. consolidated group (lower tier CFCs).

Varian filed a consolidated federal income tax return for the 2018 Year. On the return, Varian elected to claim foreign tax credits for foreign taxes that it was deemed to pay under section 960 and was therefore required to “gross up” its taxable income under section 78 by reporting a dividend of approximately $159 million. Varian also claimed a deduction of approximately $60 million under section 245A in connection with the dividend it was treated as receiving under section 78 from its first-tier CFCs.

The Commissioner examined Varian’s tax return and issued Varian a Notice of Deficiency in which, among other things, he disallowed Varian’s claimed deduction under section 245A. The Commissioner also increased Varian’s section 78 dividend by nearly $1.9 million. 3 The Commissioner further determined, in the alternative, that if Varian was entitled to deduct its section 78 dividend under section 245A, then “I.R.C. § 245A(d) would disallow any foreign tax

3 Varian does not dispute this adjustment.

credits attributable to that amount. Accordingly, [Varian’s] foreign tax credits [would] be reduced by approximately $6,362,356.”

Varian timely petitioned our Court for a redetermination of the Commissioner’s determinations. In its Petition, Varian alleged that the disallowance of its section 245A deduction was erroneous. Varian also alleged for the first time that it is entitled to additional section 245A deductions (on top of those claimed in its return) of approximately $100 million, primarily related to the portion of its section 78 dividend arising from its lower tier CFCs. The parties filed Cross-Motions for Partial Summary Judgment regarding Varian’s entitlement to a deduction related to its section 78 dividend and to the potential foreign tax credit disallowance under section 245A.

In August 2024, we issued our prior opinion, holding that Varian was entitled to a deduction under section 245A and that its foreign tax credits would be commensurately reduced by section 245A(d). Varian, 163 T.C. at 112. After working to compute the relevant amounts, Varian and the Commissioner filed the Cross-Motions for Summary Judgment now before us.

Discussion

I. Summary Judgment Standard

The purpose of summary judgment is to expedite litigation and avoid costly, time-consuming, and unnecessary trials. Fla. Peach Corp. v. Commissioner, 90 T.C. 678, 681 (1988). Summary judgment is appropriate when the movant shows there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law. Rule 121(a)(2); Sundstrand Corp. v. Commissioner, 98 T.C. 518, 520 (1992), aff’d, 17 F.3d 965 (7th Cir. 1994). In deciding whether to grant summary judgment, we construe factual materials and inferences drawn from them in the light most favorable to the adverse party. Sundstrand Corp., 98 T.C. at 520.

The parties generally agree with respect to the relevant facts, and there is no dispute that we may resolve their Motions as a matter of law.

II. Section 246

Sections 243, 245, and 245A all allow corporations, in certain circumstances, to deduct dividends they receive from other corporations. Section 243(a) generally authorizes a deduction for a portion of the

dividends received from domestic corporations. Section 245(a)(1) authorizes a deduction for the “U.S.-source portion” of dividends received from “qualified 10-percent owned foreign corporation[s].” And section 245A, as we have discussed at length, authorizes a deduction for the “foreign-source portion” of dividends received from “specified 10- percent owned foreign corporation[s].”

Free access — add to your briefcase to read the full text and ask questions with AI

Varian Medical Systems, Inc. and Subsidiaries, (tax 2026).

Varian Medical Systems, Inc. and Subsidiaries (Varian Medical Systems, Inc. and Subsidiaries) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Burnet v. Clark
287 U.S. 410 (Supreme Court, 1932)
McFeely v. Commissioner
296 U.S. 102 (Supreme Court, 1935)
Moline Properties, Inc. v. Commissioner
319 U.S. 436 (Supreme Court, 1943)
National Carbide Corp. v. Commissioner
336 U.S. 422 (Supreme Court, 1949)
Perrin v. United States
444 U.S. 37 (Supreme Court, 1979)
California v. Hodari D.
499 U.S. 621 (Supreme Court, 1991)
Connecticut National Bank v. Germain
503 U.S. 249 (Supreme Court, 1992)
Dole Food Co. v. Patrickson
538 U.S. 468 (Supreme Court, 2003)
Lamie v. United States Trustee
540 U.S. 526 (Supreme Court, 2004)
Whitfield v. United States
543 U.S. 209 (Supreme Court, 2005)
United States v. Skoien
614 F.3d 638 (Seventh Circuit, 2010)
Marx v. General Revenue Corp.
133 S. Ct. 1166 (Supreme Court, 2013)
Ford Motor Company v. United States
908 F.3d 805 (Federal Circuit, 2018)
Melida Luna-Garcia De Garcia v. William Barr, U. S
921 F.3d 559 (Fifth Circuit, 2019)
Food Marketing Institute v. Argus Leader Media
588 U.S. 427 (Supreme Court, 2019)